Rankings/OpenEvidence
OpenEvidence logo

OpenEvidence

NativeAI NativePrivateUpdated November 15, 2026

The AI search engine for clinicians — making medical knowledge accessible at the speed of a clinical decision.

Founded
2022
CEO
Daniel Nadler
HQ
New York, NY, United States
Stage
Private
Revenue
Not disclosed
Total Funding
$1.0B
Employees
201-500
Flag a data issue
Healthcare ToolsHealthcare
43.6Bluescore
Momentum67.2
Market MapStrong Distribution
Rank change (7d)▲ 40

Executive Summary

Updated Nov 12, 2026

What they do

  • AI medical search engine giving clinicians cited, evidence-based answers at the point of care
  • EHR-embedded, patient-aware clinical intelligence deployed inside Epic at large health systems
  • Adjacent clinician tools: ambient scribe, coding support, access/affordability tools and education

Why it matters

  • Reports 1.12 million verified US clinician users and tens of millions of monthly consultations
  • Content licensing with major journals and societies including ACP and ACR guidance
  • Raised $250M at $12B in January 2026, then reportedly $15B by September 2026

Best fit

  • Health systems standardizing clinical decision support across physicians, nurses and pharmacists
  • Epic-based organizations wanting evidence answers grounded in individual patient records
  • Academic medical centers modernizing medical education and point-of-care reference tools

Watch-outs

  • Free clinician tier is ad-supported, raising pharma advertising and neutrality questions
  • Enterprise EHR offering is recent; contracting, pricing and support maturity still developing
  • Rapid product sprawl into scribing and coding overlaps incumbent vendors you may already use

Products & Offerings

OpenEvidence

AI medical search engine and clinical copilot that answers clinician questions with citations to peer-reviewed literature and guidelines, free to verified US healthcare professionals.

PlatformEnterpriseFlagship2023

Patient Aware Clinical Intelligence

Enterprise EHR integration, including in Epic, that grounds OpenEvidence answers in an individual patient's chart for health-system clinicians.

EnterpriseEnterpriseHigh Growth2026

OpenEvidence Visits

Ambient AI scribe that transcribes patient encounters, drafts structured notes and adds current guidelines and research to the assessment and plan.

PlatformEnterpriseLive2025

Coding Intelligence

Evidence-backed coding and billing support that helps clinicians document and code encounters accurately.

PlatformEnterpriseEmerging2026

OpenEvidence Access Intelligence

Suite of tools built into the platform that helps clinicians handle patient affordability and access to care at the point of care.

PlatformEnterpriseEmerging2026

Recent Releases

Latest News

Analyst VerdictShortlist

Updated Nov 12, 2026

OpenEvidence has become the default AI clinical reference for many US clinicians. It now has enterprise EHR deployments at Mount Sinai, Sutter Health, Cedars-Sinai, Penn Medicine, Johns Hopkins and NYU Langone, so health systems choosing clinical decision support should put it on the shortlist next to UpToDate and Doximity. Buyers should check how the ad-supported model is governed, review answer validation and audit logging, and get written commercial terms for the Epic-integrated enterprise product. Don't assume free-tier clinician adoption means enterprise readiness.

Signal Provenance

Latest observation date and source for each signal category

Signal CategoryLast UpdatedSource
Funding Signals
Last funding round, Funding stage
Nov 10, 2026Cited web research
Hiring Velocity
Headcount, Headcount growth
Nov 11, 2026Research agents (estimate)
Technical Output
Research papers, GitHub activity
Nov 13, 2026Hugging Face Hub + news feed + research agents
News Sentiment
News mentions, News sentiment
Nov 15, 2026Verified news feed
Partnership Signals
Enterprise partnerships, Distribution partners
Nov 15, 2026Research agents (estimate)
Revenue Indicators
ARR estimate, Revenue growth
Nov 15, 2026Research agents (estimate)
Leadership Signals
CEO tenure, Founder-led
Nov 15, 2026Research agents (estimate)
Competitive Position
Category rank, Market share
Nov 15, 2026Research agents (estimate)

Why this Bluescore?

6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology

OpenEvidence's Bluescore of 43.6 rests most on Investment Momentum (6.5, top 24%) and Data & Model Moat (4.5, 61st percentile). Its weakest area is Talent & Research (2.6, 26th percentile).

In plain English

OpenEvidence has a Bluescore of 43.6 out of 100 and ranks #151 of 247. Its strongest areas are Investment Momentum, at 6.5 of 10 and the 76th percentile among the AI250, and Data & Model Moat, at 4.5 of 10 and the 61st percentile. Talent & Research is the weakest area, at 2.6 of 10 and the 26th percentile, while Product Depth, at 4.0 of 10 with a 21% weight, leaves the most points on the table with 12.6 of 21 still unclaimed, so improving it would move the score most.

Written by AI from the scores below and checked against them; updated nightly.

D1 · Business Model & Revenue (21%)
4.4
+9.2 of 21 pts · 45th pct
D2 · Product Depth (21%)
4.0
+8.4 of 21 pts · 32nd pct
D3 · Data & Model Moat (19%)
4.5
+8.5 of 19 pts · 61st pct
D4 · Talent & Research (16%)
2.6
+4.1 of 16 pts · 26th pct
D5 · Customer Adoption (13%)
5.2
+6.8 of 13 pts · 50th pct
D6 · Investment Momentum (10%)
6.5
+6.5 of 10 pts · Top 24%

Risks

Updated Nov 12, 2026

Pharma advertising revenue model may create perceived bias in clinical answer presentation
Medium
LLM answer errors in high-stakes clinical decisions require governance, validation and oversight
High
Enterprise Epic-integrated offering is new, with limited long-term reference deployments
Medium
Very high valuation relative to revenue creates pressure to change monetization terms
Medium
Crowded field: UpToDate, Doximity, Microsoft Dragon Copilot and Abridge overlap capabilities
Low
Feedback